Daily non-political popular news in brief.

Tracing agent, ultrasound combo helps test cancer therapy's effectiveness

01-08-2007 · UT Southwestern Medical Center

An inexpensive tracing agent used in combination with ultrasound can pinpoint how effectively drugs targeting pancreatic cancer work, researchers at UT Southwestern Medical Center have demonstrated for the first time.

Keywords: tracing, agent, ultrasound, combo, test, cancer, therapy, effectiveness

« Previous | Next »

Similar news on "Tracing agent, ultrasound combo helps test cancer therapy's effectiveness":

MIT radar technology fights breast cancer
11-28-2007 · Massachusetts Institute of Technology (MIT)
Treating breast cancer with a type of heat therapy derived from MIT radar research can significantly increase the effectiveness of chemotherapy, according to results from the fourth clinical trial of the technique reported online Nov. 25.
Similar news · Read more »
Study finds lapatinib shows promise as therapy for inflammatory breast cancer
12-14-2006 · EurekAlert!
In the first multi-center clinical trial conducted to better understand the complexities of a rare, aggressive and often lethal form of breast cancer, researchers have discovered that the experimental biological agent, lapatinib, successfully and specifically treats inflammatory breast cancer (IBC).
Similar news · Read more »
Cost-benefit analysis: Combo treatment costs more, saves money later
11-07-2006 · EurekAlert!
From a health insurer's perspective, the most effective cancer treatment may also be the most cost-effective, according to a new study sponsored by the Radiation Therapy Oncology Group (RTOG 91-11). Compared to higher-priced combination treatments, the least expensive, single-modality cancer treatment may cost more in the long run because of the costs associated with treating complications and recurrence of cancer.
Similar news · Read more »
Intensity-modulated radiation therapy reduces side effects for cervical cancer
11-07-2006 · EurekAlert!
Administering extended-field intensity-modulated radiation therapy (IMRT) for cervical cancer resulted in significantly reduced side effects and outcomes comparable to standard radiotherapy. In the University of Pittsburgh study, 36 patients with cervical cancer were treated with extended-field IMRT and the chemotherapy agent cisplatin to determine the efficacy of treatment and treatment-related side effects.
Similar news · Read more »
Radiation and drug combo helps boost efficacy of lung cancer treatment
09-01-2007 · EurekAlert!
Combining radiation therapy with a drug that helps destroy blood vessels nourishing malignant tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone, researchers at UT Southwestern Medical Center have found.
Similar news · Read more »
Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
02-06-2008 · EurekAlert!
Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment is more effective than radiation therapy alone for patients with intermediate risk prostate cancer.The clinical trial is part of a $9 million grant from the National Cancer Institute awarded to Henry Ford to study the effectiveness of gene therapy to treat prostate cancer.
Similar news · Read more »
Intravenous gene therapy protects normal tissue of mice during whole-body radiation
11-07-2006 · EurekAlert!
Gene therapy administered intravenously could be used as an agent to protect vital organs and tissues from the effects of ionizing radiation in the event of large-scale exposure from a radiological or nuclear bomb. In the University of Pittsburgh study, mice were used to test the protective effects of manganese superoxide dismutase plasmid liposome (MnSOD-PL) gene therapy on the bone marrow during whole-body irradiation.
Similar news · Read more »
Penn researchers identify new combination therapy that promotes cancer cell death
07-16-2007 · EurekAlert!
To test the ability of combined therapy, researchers administered TRAIL, a tumor necrosis factor, and sorafenib, an inhibitor currently used to treat renal cancer, to mice with colon carcinomas. It reduced the size of tumors in mice with few side effects
Similar news · Read more »
Blood-vessel blocker aids cancer-killing virus
11-27-2007 · EurekAlert!
Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly eliminate them. That immune response might be slowed, and the virus given more time to kill cancer cells, by blocking the growth of blood vessels in the tumor, new Ohio State research suggests. The study indicates that pretreatment with a drug that blocks blood-vessel growth might improve the effectiveness of cancer-killing viruses.
Similar news · Read more »
New Jefferson trial to test radiation-emitting beads against advanced liver cancer
02-12-2008 · EurekAlert!
Liver cancer specialists at Jefferson's Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver's main artery while also blocking the blood supply feeding the cancer’s growth.
Similar news · Read more »